PHARMAC responds on agents to prevent osteoporotic fractures.
Metcalfe
Scott
S
Wilkinson
Tommy
T
Rasiah
Dilky
D
D050071:Bone Density Conservation Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000191:economics* / Q000627:therapeutic use; D017277:Drug Approval / Q000191:economics*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D009520:New Zealand; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates